# Effect of Intracameral Injection of Mydriatic Plus Anaesthetic Combination on Corneal Endothelial Count in Phaco

> **NCT04396301** · PHASE3 · COMPLETED · sponsor: **Cairo University** · enrollment: 30 (actual)

## Conditions studied

- Corneal Endothelial Cell Loss
- Mydriasis
- Cataract

## Interventions

- **DRUG:** Fydrane®: (Manufacturer DELPHARM TOURS, FRANCE).

## Key facts

- **NCT ID:** NCT04396301
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-01
- **Primary completion:** 2019-08-30
- **Final completion:** 2019-09-30
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04396301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04396301, "Effect of Intracameral Injection of Mydriatic Plus Anaesthetic Combination on Corneal Endothelial Count in Phaco". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04396301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*